Beam Therapeutics Inc.

BEAM · Healthcare · · USD

35.82 USD

0.00 (-2.87%)

● Updated 2026-07-10 16:11 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score STRONG BUY Mid-term (Position)

/ 100

Technical 100

Trend & RS 98

Momentum 77

Fundamental 33

Macro 78

Liquidity 44

Component	Score	Weight
Technical	100.0	20%
Trend & RS	97.6	30%
Momentum	77.4	15%
Fundamental	33.3	10%
Macro	78.4	20%
Liquidity	43.8	5%

Trade Setup

Entry	35.82
Stop Loss	30.64 (14.5%)
Target 1 (1:1)	41.00 (+14.5%)
Target 2 (2:1)	46.18 (+28.9%)

ATR(14)	2.59 (7.2%)
Risk per Share	5.18
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	73.1	+0.92
Momentum	77.4	+1.10
Quality	36.2	-0.55
Composite	62.2

Quality Scores

Piotroski F-Score 3 /9 — Weak

✗ ✗ ✗ ✗ ✓ ✓ ✗ ✗ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score Insufficient Data

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	N/A	22.0	Inline
P/B Ratio	3.1	4.0	Below

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Position Sizing — Kelly Criterion

4.8%

Recommended Size

52.66%

Full Kelly

26.33%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 82/100. Estimated win rate 65%, avg win 9.9%, avg loss 3.4%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

RECOVERY Regime: RECOVERY (20% confidence) — position size reduced 4%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

58.38

RSI(14)

1.5237

MACD

Relative Strength (RS) IMPROVING

/ 99

RS Rating

✓ O'Neil PASS (≥80)

RS vs SPY	↑ RISING (+29.3% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	No (2d since high)
Sector Outperformance	+31.3% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

Indicator	Value	Signal
Rsi	58.38	NEUTRAL
Macd	1.5237	BULLISH
Ma Cross	31.53 / 27.89	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.95x	NORMAL

Key Levels

Level	Price
52-Week High	38.26
Bollinger Upper	38.53
SMA(200)	27.89
SMA(50)	31.53
SMA(20)	33.58
Current Price	35.82
Bollinger Lower	28.62
52-Week Low	15.60
ATR(14)	2.59

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence

100%

Acc: 0.0 | Dist: 0.0 | Markup: 2.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-07-02	Normal	0.88x	Normal bar — no special VSA pattern
2026-07-06	Normal	0.91x	Normal bar — no special VSA pattern
2026-07-07	Normal	1.49x	Normal bar — no special VSA pattern
2026-07-08	Normal	1.49x	Normal bar — no special VSA pattern
2026-07-09	Normal	0.95x	Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

Line	Value	Status
Tenkan-sen (9)	35.55	Above Kijun
Kijun-sen (26)	33.28	Base line
Senkou A	34.41	Leading span A
Senkou B	32.06	Leading span B
Cloud	32.06 – 34.41	Bullish (Green)
Price vs Cloud	35.82	Above Cloud
Chikou Span	28.96	Bullish
Alignment Score	4/4	BULLISH